Mark Trentalange Selected Research

Mark Trentalange Research Topics

3	Human Influenza (Influenza) 04/2016 - 01/2015
2	Pyuria 03/2018 - 11/2016
2	Bacteriuria 03/2018 - 11/2016
2	Atrial Fibrillation 01/2016 - 10/2015
1	Pain (Aches) 01/2019
1	Osteoarthritis 01/2019
1	Cognitive Dysfunction 10/2018
1	Urinary Tract Infections (Urinary Tract Infection) 11/2016
1	Diabetes Mellitus 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016
1	Endometriosis 01/2016
1	Heart Failure 01/2016
1	Chronic Disease (Chronic Diseases) 01/2015
1	Frailty 01/2015
1	Drug-Related Side Effects and Adverse Reactions 12/2014
1	Sepsis (Septicemia) 04/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2014
1	Emphysema 03/2014

3	CytokinesIBA 01/2016 - 03/2014
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2019
1	Guanfacine (Tenex)FDA LinkGeneric 10/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2016
1	Antiviral Agents (Antivirals)IBA 04/2016
1	N,N-dimethyl-4-anisidine (DMPA)IBA 01/2016
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2016
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2016
1	Warfarin (Coumadin)FDA LinkGeneric 10/2015
1	Interleukin-10 (Interleukin 10)IBA 04/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2015
1	SolutionsIBA 01/2015
1	VaccinesIBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 04/2014
1	Macrophage Migration-Inhibitory FactorsIBA 03/2014
1	macrophage migration inhibitory factor receptorIBA 03/2014
1	SmokeIBA 03/2014